The gut microbiome is a significant risk factor for future chronic lung disease-Reference-Cited by-同舟云学术

The gut microbiome is a significant risk factor for future chronic lung disease

Published:2023-04 Issue:4 Volume:151 Page:943-952
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Liu Yang^ORCID,Teo Shu Mei,Méric Guillaume,Tang Howard H.F.,Zhu Qiyun,Sanders Jon G.,Vázquez-Baeza Yoshiki,Verspoor Karin,Vartiainen Ville A.,Jousilahti Pekka,Lahti Leo,Niiranen Teemu,Havulinna Aki S.,Knight Rob,Salomaa Veikko,Inouye Michael

Funder

British Heart Foundation

NIHR Cambridge Biomedical Research Centre

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference75 articles.

1. Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease;Halpin;Am J Respir Crit Care Med,2021

2. Global Initiative for Asthma, Global strategy for asthma management and prevention, 2020. Available from: www.ginasthma.org

3. Asthma;Papi;Lancet,2018

4. Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes;Barnes;J Allergy Clin Immunol,2015

5. Chronic obstructive pulmonary disease phenotypes: implications for care;Mirza;Mayo Clin Proc,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promising dawn in the management of pulmonary hypertension: The mystery veil of gut microbiota;iMeta;2024-01

2. Harnessing human microbiomes for disease prediction;Trends in Microbiology;2024-01

3. Imbalance of gut microbiota is involved in the development of chronic obstructive pulmonary disease: A review;Biomedicine & Pharmacotherapy;2023-09

4. Integration of polygenic and gut metagenomic risk prediction for common diseases;2023-08-05

5. New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis;Clinical Science;2023-05